Answer
Glomerulonephritis has been reported in patients and donors receiving lenograstim, generally resolving after G-CSF dose reduction or withdrawal, and urinalysis monitoring is recommended.
Sources for this answer
- Granocyte 13 million IU, and 34 million IUChugai Pharma UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 22Document updated
Sources checked